Consequently, we performed a retrospective study on patients with KIT mutant (KIT mut)/CBF-neg AML and investigated the clinical characteristics, treatment procedures and survival to provide preliminary clues into the individual treatment strategy of the subgroup. Here, KIT is linked to acute myeloid leukemia.